Notice2025-17999
National Heart, Lung, and Blood Institute; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 17, 2025
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 178 (Wednesday, September 17, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 178 (Wednesday, September 17, 2025)]
[Notices]
[Pages 44834-44835]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-17999]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Heart,
Lung, and Blood Advisory Council.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Advisory
Council.
Date: October 29, 2025.
[[Page 44835]]
Closed: 8:00 a.m. to 8:30 a.m.
Agenda: To Review and Evaluate Grant Applications.
Address: National Institutes of Health, Claude D. Pepper
Building, 31 Center Drive, Bethesda, MD 20894.
Meeting Format: In-Person.
Contact Person: Charisee Lamar, Ph.D., M.P.H., R.R.T., Director,
Division of Extramural Research Activities, National Heart, Lung,
and Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 206-Q, Bethesda, MD 20892, 301-827-5517,
<a href="/cdn-cgi/l/email-protection#315d505c504352715c50585d1f5f58591f565e47"><span class="__cf_email__" data-cfemail="2c404d414d5e4f6c414d454002424544024b435a">[email protected]</span></a>.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: <a href="https://www.nhlbi.nih.gov/about/advisory-and-peer-review-committees/advisory-council">https://www.nhlbi.nih.gov/about/advisory-and-peer-review-committees/advisory-council</a>, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: September 12, 2025.
Denise M. Santeufemio,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2025-17999 Filed 9-16-25; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 17, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.